Strength 400 mg/16 ml Brand Bevazza Active Ingredient Bevacizumab Pharmaceutical Form sterile, clear to slightly opalescent, and colorless to pale yellow liquid concentrate for…
Strength 400 mg/16 ml
Brand Bevazza
Active Ingredient Bevacizumab
Pharmaceutical Form sterile, clear to slightly opalescent, and colorless to pale yellow liquid concentrate for Intravenous (I.V.) Infusion.
Volume 16 ml
Packaging Type Vial
Country of Origin Made in India
Manufacturer Lupin
Warning and Precaution Not to be taken by Pregnant Women
Dosage Form 400/100 mg
Usage /Application Anti Cancer
Composition Bevacizumab Injection IP
Minimum order quantity: 50 Vial
BEVAZZA Bevacizumab (400 mg/16 mL) is a targeted monoclonal antibody (anti-angiogenic). It is administered via intravenous infusion to treat various advanced cancers by stopping tumors from creating new blood vessels to grow. Treatment must be prescribed and administered by a healthcare professional.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Detailed description not available for this product.
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
